← SynDRA
INDACATEROL
SynDRA canonical compound SYN0021956 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | ADRB2 |
|---|
| Mechanism of action | Adrenergic receptor agonist |
|---|
| Indication | chronic obstructive pulmonary disease (COPD) |
|---|
| Disease area | pulmonary |
|---|
All known targets
- ADRB2
- ADRB1
- Adrb2
- CYP1B1
- DRD2
- DRD3
Mechanisms of action (all sources)
- Adrenergic receptor agonist
- ADRB2 AGONIST
- Beta-2 adrenergic receptor agonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- HTR1D
- HTR2B
- HTR2A
- SLC6A2
- SLC6A4
- HTR2C
- SLC6A3
- ADRA1A
- TMEM97
- ADRA1D
- ADRA1B
- MUTYH
- HTR3A
- HTR5A
- HTR6
- HTR7
- MBD4
- MPG
- ADGRF1
- NEIL1
- NEIL2
- NTHL1
- OPRD1
- OPRM1
- S1PR1
- SIGMAR1
- SMUG1
- SRSF6
- TDG
- OGG1
- HTR1B
- HTR1E
- HTR1A
- ADRA2A
- ADRA2B
- ADRA2C
- AGTR1
- ALB
- APLNR
- C5AR1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Adrenergic beta2-Agonists
- beta2-Adrenergic Agonist
ATC classes
- R03A · ADRENERGICS, INHALANTS
Cross-references
Synonyms
- ARCAPTA NEOHALER
- UTIBRON NEOHALER
- QAB149
- QAB 149
- Arcapta Neohaler
- indacaterol maleate
- Indacterol
- Onbrez
- QAB-149
- QABI49
- Arcapta
- UNII-8OR09251MQ
- CHEMBL1095777
- CHEBI:68575
- 8OR09251MQ
- Indacaterol Maleic Acid Salt
- Indacaterol (USAN/INN)
- Indacaterol [USAN:INN:BAN]
- Indacaterol/mometasone
- indacaterolum
- RefChem:790882
- DTXCID00107689
- R03AC18
- MFCD18782702
- Indacaterol [INN]
- Indacaterol (Standard)
- INDACATEROL [MI]
- INDACATEROL [USAN]
- INDACATEROL [VANDF]
- INDACATEROL [MART.]
- SCHEMBL48098
- INDACATEROL [WHO-DD]
- GTPL7455
- orb1305700
- SCHEMBL29350045
- SCHEMBL29367297
- QZZUEBNBZAPZLX-QFIPXVFZSA-N
- GLXC-90393
Look up INDACATEROL in the interactive SynDRA portal →